Position in AMRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,424,197
-$386,974 QoQ
Shares Held
355,929
-6.8% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $52,013,067 across 12 Drug Manufacturers - Specialty & Generic names. AMRX ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,089,480 | $14,718,874 | |
| 2 | LQDA |
Liquidia Corp
|
204,060 | $7,701,224 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,156,958 | $6,710,356 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
222,840 | $5,332,561 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
355,929 | $4,424,197 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
6,160 | $3,652,756 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
47,568 | $2,630,986 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
19,970 | $2,630,847 |
All Filings in AMRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,424,197 | 355,929 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,811,171 | 381,839 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,510,881 | 950,138 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,422,207 | 1,041,064 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,699,361 | 560,783 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,532,280 | 445,995 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,729,073 | 448,206 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,874,797 | 452,724 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,461,493 | 406,187 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,860,758 | 306,550 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,027,992 | 243,600 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $587,636 | 189,560 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $370,854 | 266,802 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $657,611 | 330,458 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $444,133 | 219,868 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $754,171 | 237,161 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,217,886 | 292,059 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $484,714 | 101,193 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,009,457 | 189,037 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $526,643 | 102,860 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $316,242 | 46,990 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||